Comparing two exponential distributions using the exact likelihood ratio test

Statistics in Biopharmaceutical Research

Volumn 4, Issue 4, 2012, Pages 348-356

  Han, Gang ^a   Schell, Michael J ^a,b   Kim, Jongphil ^a,b  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Exponential family; Power calculation; Survival analysis; Uniformly most powerful unbiased test

Indexed keywords

BIOLOGICAL MARKER;

ALGORITHM; ALTERNATIVE HYPOTHESIS; ALTERNATIVE MEDICINE; ARTICLE; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAXIMUM LIKELIHOOD METHOD; NULL HYPOTHESIS; OVERALL SURVIVAL; PERSONALIZED MEDICINE; PROBABILITY; PROGRESSION FREE SURVIVAL; SAMPLE SIZE; VARIANCE;

EID: 84867381438     PISSN: None     EISSN: 19466315     Source Type: Journal    
DOI: 10.1080/19466315.2012.698945     Document Type: Article

References (12)

1. Basu, D. (1958), "On Statistics Independent of a Sufficient Statistic," Sankhyā, 20, 223-226.
2. Bui, M., Han, G., Acs, G., Gonzalez, R., Reed, D., Pasha, I.L., and Zhang, P. (2011), "Connexin 43 Is a Potential Prognostic Biomarker for Ewing Sarcoma (EWS)/Primitive Neuroectodermal Tumor (PNET)," Sarcoma. Article ID: 971050, doi:10.1155/2011/971050.
3. Cox, D.R. (1953), "Some Simple Approximate Tests for Poisson Variates," Biometrika, 40, 354-360.
4. Epstein, B., and Sobel, M. (1954), "Some Theorems Relevant to Life Testing From an Exponential Distribution," The Annals of Mathematical Statistics, 25, 373-381.
5. Hollander, M., and Proschan, F. (1979), "Testing to Determine the Underlying Distribution Using Randomly Censored Data," Biometrics, 35, 393-401.
6. Kalbfleisch, J.D., and Prentice, R.L. (1980), The Statistical Analysis of Failure Time Data, New York: Wiley.
7. ee, E.T. (1992), Statistical Methods for Survival Data Analysis, New York: Wiley.
8. Lehmann, E.L. (1986), Testing Statistical Hypotheses, New York: Springer.
9. Meier, P., Karrison, T., Chappell, R., and Xie, H. (2004), "The Price of Kaplan-Meier," Journal of the American Statistical Association, 99, 890-896.
10. Miller, R.G. (1983), "What Price Kaplan-Meier?" Biometrics, 39, 1077-1081.
11. Simon, G.R., Schell, M.J., Begum, M., Haura, J.K.E., Antonia, S.J., and Bepler, G. (2012), "Preliminary Indication of Survival Benefit From ERCC1 and RRM1-Tailored Chemotherapy in Patients With Advanced Nonsmall Cell Lung Cancer: Evidence From an Individual Patient Analysis," Cancer, 118, 2525-2531.
12. Tate, R.F., and Klett, G.W. (1959), "Optimal Confidence Intervals for the Variance of a Normal Distribution," Journal of the American Statistical Association, 54, 674-682.